Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.83 - $21.25 $9,222 - $236,108
-11,111 Reduced 27.26%
29,655 $19,000
Q1 2022

May 13, 2022

BUY
$1.63 - $3.63 $264 - $588
162 Added 0.4%
40,766 $109,000
Q4 2021

Feb 08, 2022

SELL
$2.25 - $4.11 $951 - $1,738
-423 Reduced 1.03%
40,604 $91,000
Q3 2021

Nov 15, 2021

BUY
$2.71 - $5.9 $80,064 - $174,309
29,544 Added 257.28%
41,027 $166,000
Q2 2021

Aug 13, 2021

BUY
$4.83 - $9.67 $55,462 - $111,040
11,483 New
11,483 $57,000

About Vivos Therapeutics, Inc.


  • Ticker VVOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 23,012,100
  • Market Cap $78.2M
  • Description
  • Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...
More about VVOS
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.